PLX · Protalix BioTherapeutics, Inc.
$2.30
+0.08 (+3.60%)
At close · Aug 17
Market Cap
$178.87M
Shares
80.57M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1006281
CUSIP
74365A309
13F (30d)
98 filings
96 filers
Visit website
Investor relations